PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cellsChangjiang Qin(Henan University Huaihe Hospital and Huaihe Clinical Institute), Xinming Song(Sun Yat-sen University)Cell Death and DiseaseMay 28, 202210.1038/s41419-022-04967-7Cited by 37SaveCiteExport RISWatch citationsRelated PapersCCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis|Cancer Cell|2024|152